-
May 2, 2024, 3:35 pm63 ptsDrug manufacturing giant GlaxoSmithKline (GSK) is subverting its pledge to lower the price of its brand-name inhaler products, a key Democratic senator alleged. In a letter to CEO Emma Walmsley made public Thursday, Sen. Maggie Hassan (D-N.H.) said the company appears to be circumventing its…
Welcome to Politomix -- the political news wire where left, right and center mix.
Politomix aggregates the day's political news on the web and your mobile device.